Literature DB >> 12652171

Classifications and practice guidelines in atrial fibrillation: a changing landscape.

Sanjeev Saksena1.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12652171     DOI： 10.1023/a:1022384924732

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN： 1383-875X            Impact factor:   1.900


× No keyword cloud information.
  15 in total

1.  Don't you agree, or what part of the problem don't you understand?

Authors:  A J Camm; S Levy; S Saksena; D G Wyse
Journal:  J Interv Card Electrophysiol       Date:  2000-12       Impact factor: 1.900

2.  Report of the NASPE/NHLBI round table on future research directions in atrial fibrillation.

Authors:  S Saksena; M J Domanski; E J Benjamin; A J Camm; M D Ezekowitz; B J Gersh; J Jalife; G V Naccarelli; R E Vlietstra; D G Wyse
Journal:  Pacing Clin Electrophysiol       Date:  2001-09       Impact factor: 1.976

3.  Ionic mechanisms of electrical remodeling in human atrial fibrillation.

Authors:  R F Bosch; X Zeng; J B Grammer; K Popovic; C Mewis; V Kühlkamp
Journal:  Cardiovasc Res       Date:  1999-10       Impact factor: 10.787

4.  Regional endocardial mapping of spontaneous and induced atrial fibrillation in patients with heart disease and refractory atrial fibrillation.

Authors:  S Saksena; A Prakash; R B Krol; A Shankar
Journal:  Am J Cardiol       Date:  1999-10-15       Impact factor: 2.778

5.  Catheter ablation of inducible atrial flutter, in combination with atrial pacing and antiarrhythmic drugs ("hybrid therapy") improves rhythm control in patients with refractory atrial fibrillation.

Authors:  Atul Prakash; Sanjeev Saksena; Ryszard B Krol; Artur Filipecki; George Philip
Journal:  J Interv Card Electrophysiol       Date:  2002-06       Impact factor: 1.900

6.  Atrial L-type Ca2+ currents and human atrial fibrillation.

Authors:  D R Van Wagoner; A L Pond; M Lamorgese; S S Rossie; P M McCarthy; J M Nerbonne
Journal:  Circ Res       Date:  1999-09-03       Impact factor: 17.367

7.  Electrophysiology and endocardial mapping of induced atrial fibrillation in patients with spontaneous atrial fibrillation.

Authors:  S Saksena; I Giorgberidze; R Mehra; M Hill; A Prakash; R B Krol; P Mathew
Journal:  Am J Cardiol       Date:  1999-01-15       Impact factor: 2.778

8.  Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype.

Authors:  J Sadoshima; S Izumo
Journal:  Circ Res       Date:  1993-09       Impact factor: 17.367

9.  Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy.

Authors:  Sanjeev Saksena; Atul Prakash; Paul Ziegler; John D Hummel; Paul Friedman; Vance J Plumb; D George Wyse; Eric Johnson; Stephanie Fitts; Rahul Mehra
Journal:  J Am Coll Cardiol       Date:  2002-09-18       Impact factor: 24.094

10.  Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study.

Authors:  Antonio H Madrid; Manuel G Bueno; Jose M G Rebollo; Irene Marín; Gonzalo Peña; Enrique Bernal; Aníbal Rodriguez; Lucas Cano; José M Cano; Pedro Cabeza; Concepción Moro
Journal:  Circulation       Date:  2002-07-16       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.